Advances in nanomaterials for treatment of hypoxic tumor

Author:

Zou Mei-Zhen1,Liu Wen-Long2,Chen Han-Shi1,Bai Xue-Feng1,Gao Fan1,Ye Jing-Jie1,Cheng Han1,Zhang Xian-Zheng1ORCID

Affiliation:

1. The Institute for Advanced Studies, Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, China

2. School of Chemistry and Materials Science, South-Central University for Nationalities, Wuhan 430074, China

Abstract

Abstract The hypoxic tumor microenvironment is characterized by disordered vasculature and rapid proliferation of tumors, resulting from tumor invasion, progression and metastasis. The hypoxic conditions restrict efficiency of tumor therapies, such as chemotherapy, radiotherapy, phototherapy and immunotherapy, leading to serious results of tumor recurrence and high mortality. Recently, research has concentrated on developing functional nanomaterials to treat hypoxic tumors. In this review, we categorize such nanomaterials into (i) nanomaterials that elevate oxygen levels in tumors for enhanced oxygen-dependent tumor therapy and (ii) nanomaterials with diminished oxygen dependence for hypoxic tumor therapy. To elevate oxygen levels in tumors, oxygen-carrying nanomaterials, oxygen-generating nanomaterials and oxygen-economizing nanomaterials can be used. To diminish oxygen dependence of nanomaterials for hypoxic tumor therapy, therapeutic gas-generating nanomaterials and radical-generating nanomaterials can be used. The biocompatibility and therapeutic efficacy of these nanomaterials are discussed.

Funder

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Multidisciplinary

Reference148 articles.

1. Exploiting tumour hypoxia in cancer treatment;Brown;Nat Rev Cancer,2004

2. Targeting hypoxia in cancer therapy;Wilson;Nat Rev Cancer,2011

3. Hypoxic control of metastasis;Rankin;Science,2016

4. The hypoxic tumour microenvironment;Petrova;Oncogenesis,2018

5. Modulating tumor hypoxia by nanomedicine for effective cancer therapy;Jahanban-Esfahlan;J Cell Physiol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3